Ewing Sarcoma

Research

Mayo Clinic researchers are currently evaluating various molecular changes caused by Ewing sarcoma. These studies are evidence of Mayo's cutting-edge efforts to search for new methods to diagnose and treat Ewing sarcoma and other cancers.

Children's Oncology Group (COG)

Mayo Clinic performs research and provides treatment as a member of the Children's Oncology Group (COG), a national children's cancer research group. Research focuses on therapeutic, epidemiological and biological studies in pediatric patients with cancers. During the last half of the 20th century, childhood cancer went from an almost universally fatal disease to one that is curable in many patients. The increasing survival of children with cancer has resulted in the recognition of the need to reduce long-term side effects of cancer and improve quality of life.

Recently, the major pediatric clinical trials groups based in North America combined efforts as part of the Children's Oncology Group, to accelerate the goal of curing and eventually preventing cancer in children and adolescents. The group will continue to perform clinical and research trials to define optimal treatment for children and adolescents with cancer. This research is expected to bring about more effective treatments with reduced short- and long-term side effects. Researchers hope to identify causes of childhood cancer, develop strategies for prevention, and improve the quality of life for children and adolescents with cancer. The work of the Children's Oncology Group will foster partnerships on behalf of children and adolescents throughout the world.